CONTROLADORA VUELA SPON ADR REPR 10 CPOS

Updates from The Motley Fool

Latest updates on Acceleron Pharma from Fool.com.
Stocks To Watch in Orphan Drugs

Acceleron Pharma, bluebird bio, and Sarepta Therapeutics are three rare disease specialists with ...

Jun 9 2015  •  Fool.com
View More Headlines »

Stock Performance

View Interactive XLRN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Acceleron Pharma.
Current Price: $35.34
Prev Close: $35.42
Open: $35.57
Bid: $35.03
Ask: $45.59
Day's Range: $34.65 - $35.70
52wk Range: $24.37 - $46.93
Volume: 398,800
Avg Vol 274,172
Market Cap: $2B
P/E (ttm): -13.22
EPS (ttm): ($2.68)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Acceleron Pharma.
CAPS Rating 5 out of 5
 
33 Outperform
1 Underperform
CAPS All Stars
 
11 Outperform
0 Underperform

How do you think Acceleron Pharma will perform against the market?

Modal Outperform

Modal Underperform



You pick for Acceleron Pharma is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.
Habib Dable, CEO

Habib Dable, CEO

100% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Acceleron Pharma.

CONTROLADORA VUELA SPON ADR REPR 10 CPOS

  • Exchange: NASDAQ